Related Experiment Video
Updated: Jul 19, 2026

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
Published on: January 7, 2019
Reversible Parkinsonism linked to trimetazidine (continued)
Abstract:
(1) In a series of 128 neurological patients taking trimetazidine, 56 developed motor disorders that improved or resolved when trimetazidine was withdrawn. (2) New cases of parkinsonism, gait disorders and tremor that resolved or improved after trimetazidine withdrawal have been reported in France. (3) As there is no evidence that trimetazidine is effective, there is no justification for placing patients at risk for parkinsonism. (4) Patients who develop motor disorders while taking trimetazidine have everything to gain and nothing to lose by discontinuing treatment. There is no possible justification for initiating treatment with trimetazidine.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Alterations in Muscle Tone lll
